Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Everolimus
1
Bone marrow metastatic neuroendocrine carcinoma with unknown primary site: A case report and review of the literature
10/21/2022 2:24:59 AM |
Browse: 205 |
Download: 454
2
Current aspects of renal dysfunction after liver transplantation
1/21/2022 8:16:14 AM |
Browse: 331 |
Download: 732
3
Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - An update on neuroendocrine neoplasm’s treatment: A case report
5/20/2021 3:14:20 PM |
Browse: 375 |
Download: 773
4
Safety and performance of the EverProTM everolimus-eluting coronary stent system with biodegradable polymer in a real-world scenario
12/17/2020 9:42:32 AM |
Browse: 511 |
Download: 1049
5
Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer
12/21/2018 1:32:15 AM |
Browse: 790 |
Download: 818
6
Introduction of everolimus in kidney transplant recipients at a late posttransplant stage
9/7/2018 6:15:25 AM |
Browse: 797 |
Download: 1275
7
Use of everolimus in liver transplantation
8/18/2017 1:45:25 AM |
Browse: 951 |
Download: 1026
8
Benefit of everolimus in treatment of an intrahepatic cholangiocarcinoma patient with a PIK3CA mutation
6/20/2017 12:12:53 PM |
Browse: 826 |
Download: 1227
9
Translating new data to the daily practice in second line treatment of renal cell carcinoma: The role of tumor growth rate
4/7/2017 8:24:12 AM |
Browse: 944 |
Download: 1067
10
Growth hormone abolishes the negative effects of everolimus on intestinal wound healing
4/29/2016 4:50:00 PM |
Browse: 1257 |
Download: 1895
11
Sequential treatment in disseminated well- and intermediate-differentiated pancreatic neuroendocrine tumors: Common sense or low rationale?
4/7/2016 11:01:00 AM |
Browse: 995 |
Download: 1482
12
Medical treatment for gastro-entero-pancreatic neuroendocrine tumours
3/30/2016 2:15:00 PM |
Browse: 945 |
Download: 1355
13
Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis
3/21/2016 8:54:00 AM |
Browse: 950 |
Download: 1212
14
Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantation
3/18/2016 2:28:00 PM |
Browse: 1091 |
Download: 1455
15
Twelve-month efficacy and safety of the conversion to everolimus in maintenance heart transplant recipients
12/23/2015 8:26:00 AM |
Browse: 921 |
Download: 1644
16
Combining cytochrome P-450 3A4 modulators and cyclosporine or everolimus in transplantation is successful
12/23/2015 8:26:00 AM |
Browse: 872 |
Download: 2003
17
Excellent long term patient and renal allograft survival after ABO-incompatible kidney transplantation: Experience of one center
12/23/2015 8:26:00 AM |
Browse: 1234 |
Download: 2364
18
Neuroendocrine tumors resistant to mammalian target of rapamycin inhibitors: A difficult conversion from biology to the clinic
12/9/2015 6:37:00 PM |
Browse: 929 |
Download: 1308
19
Mammalian target of rapamycin inhibition in hepatocellular carcinoma
12/2/2015 12:16:00 PM |
Browse: 1062 |
Download: 1176
20
Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges
4/19/2015 5:46:00 PM |
Browse: 1087 |
Download: 1461
21
Overcoming endocrine resistance in metastatic breast cancer: Current evidence and future directions
12/11/2014 2:06:00 PM |
Browse: 1022 |
Download: 1147
22
Amenorrhea as a rare drug-related adverse event associated with everolimus for pancreatic neuroendocrine tumors
11/17/2014 3:13:00 PM |
Browse: 912 |
Download: 1093
23
Hepatitis B reactivation related to everolimus
9/10/2014 3:18:00 PM |
Browse: 901 |
Download: 510
24
Everolimus immunosuppression reduces the serum expression of fibrosis markers in liver transplant recipients
8/25/2014 9:54:00 AM |
Browse: 856 |
Download: 949
25
Multiple indications for everolimus after liver transplantation in current clinical practice
8/25/2014 9:54:00 AM |
Browse: 906 |
Download: 821
Page 1 of 1 ( 25 items )
<<
1
>>
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345